相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Adenine base editor-mediated correction of the common and severe IVS1-110 (G>A) β-thalassemia mutation
Giulia Hardouin et al.
BLOOD (2023)
Betibeglogene Autotemcel Gene Therapy for Non-β0/β0 Genotype β-Thalassemia
Franco Locatelli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
ON-target Adverse Events of CRISPR-Cas9 Nuclease: More Chaotic than Expected
Julian Boutin et al.
CRISPR JOURNAL (2022)
Strategies for Enhancing the Homology-directed Repair Efficiency of CRISPR-Cas Systems
Wenli Sun et al.
CRISPR JOURNAL (2022)
Safe and efficient in vivo hematopoietic stem cell transduction in nonhuman primates using HDAd5/35++ vectors
Chang Li et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2022)
In Vivo Hematopoietic Stem Cell Genome Editing: Perspectives and Limitations
Nikoletta Psatha et al.
GENES (2022)
HIC2 controls developmental hemoglobin switching by repressing BCL11A transcription
Peng Huang et al.
NATURE GENETICS (2022)
CRISPR-Cas9-mediated gene editing of the BCL11A enhancer for pediatric β0/β0 transfusion-dependent β-thalassemia
Bin Fu et al.
NATURE MEDICINE (2022)
Gene Editing-Based Technologies for Beta-hemoglobinopathies Treatment
Ilnaz Rahimmanesh et al.
BIOLOGY-BASEL (2022)
Base-editing-mediated dissection of a γ-globin cis-regulatory element for the therapeutic reactivation of fetal hemoglobin expression
Panagiotis Antoniou et al.
NATURE COMMUNICATIONS (2022)
Co-Treatment of Erythroid Cells from β-Thalassemia Patients with CRISPR-Cas9-Based β039-Globin Gene Editing and Induction of Fetal Hemoglobin
Lucia Carmela Cosenza et al.
GENES (2022)
Regulation of Fetal Hemoglobin Production in Adult Erythroid Cells By Protein Phosphatase 6C (PPP6C)
Scott A. Peslak et al.
BLOOD (2022)
DNA double-strand break repair: Putting zinc fingers on the sore spot
Jenny Kaur Singh et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2021)
HIC2 Controls Developmental Hemoglobin Switching By Repressing BCL11A Transcription
Peng Huang et al.
BLOOD (2021)
Enhanced prime editing systems by manipulating cellular determinants of editing outcomes
Peter J. Chen et al.
CELL (2021)
ZNF410 Uniquely Activates the NuRD Component CHD4 to Silence Fetal Hemoglobin Expression
Xianjiang Lan et al.
MOLECULAR CELL (2021)
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
H. Frangoul et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Success Stories and Challenges Ahead in Hematopoietic Stem Cell Gene Therapy: Hemoglobinopathies as Disease Models
Evangelia Yannaki et al.
HUMAN GENE THERAPY (2021)
Quantitative evaluation of chromosomal rearrangements in gene-edited human stem cells by CAST-Seq
Giandomenico Turchiano et al.
CELL STEM CELL (2021)
Gene editing to enhance the efficacy of cancer cell therapies
Tara Murty et al.
MOLECULAR THERAPY (2021)
Discrete regulatory modules instruct hematopoietic lineage commitment and differentiation
Grigorios Georgolopoulos et al.
NATURE COMMUNICATIONS (2021)
Whole chromosome loss and genomic instability in mouse embryos after CRISPR-Cas9 genome editing
Stamatis Papathanasiou et al.
NATURE COMMUNICATIONS (2021)
In vivo HSPC gene therapy with base editors allows for efficient reactivation of fetal gamma-globin in beta-YAC mice
Chang Li et al.
BLOOD ADVANCES (2021)
Chromothripsis as an on-target consequence of CRISPR-Cas9 genome editing
Mitchell L. Leibowitz et al.
NATURE GENETICS (2021)
Targeting ZNF410 as a potential β-hemoglobinopathy therapy
Laxminath Tumburu et al.
NATURE GENETICS (2021)
ZNF410 represses fetal globin by singular control of CHD4
Divya S. Vinjamur et al.
NATURE GENETICS (2021)
Enhanced HbF reactivation by multiplex mutagenesis of thalassemic CD34+ cells in vitro and in vivo
Nikoletta Psatha et al.
BLOOD (2021)
Prime editing - an update on the field
Janine Scholefield et al.
GENE THERAPY (2021)
The transcription factor BCL11A defines distinct subsets of midbrain dopaminergic neurons
Marianna Tolve et al.
CELL REPORTS (2021)
TALENs-an indispensable tool in the era of CRISPR: a mini review
Anuradha Bhardwaj et al.
JOURNAL OF GENETIC ENGINEERING AND BIOTECHNOLOGY (2021)
The Promise and the Hope of Gene Therapy
Eleni Papanikolaou et al.
FRONTIERS IN GENOME EDITING (2021)
Base and Prime Editing Technologies for Blood Disorders
Panagiotis Antoniou et al.
FRONTIERS IN GENOME EDITING (2021)
Reactivation of γ-globin expression through Cas9 or base editor to treat β-hemoglobinopathies
Liren Wang et al.
CELL RESEARCH (2020)
Prime Editing: A New Way for Genome Editing
Marek Marzec et al.
TRENDS IN CELL BIOLOGY (2020)
Editing a γ-globin repressor binding site restores fetal hemoglobin synthesis and corrects the sickle cell disease phenotype
Leslie Weber et al.
SCIENCE ADVANCES (2020)
The HRI-regulated transcription factor ATF4 activates BCL11A transcription to silence fetal hemoglobin expression
Peng Huang et al.
BLOOD (2020)
Directed evolution of adenine base editors with increased activity and therapeutic application
Nicole M. Gaudelli et al.
NATURE BIOTECHNOLOGY (2020)
Therapeutic base editing of human hematopoietic stem cells
Jing Zeng et al.
NATURE MEDICINE (2020)
Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors
Andrew V. Anzalone et al.
NATURE BIOTECHNOLOGY (2020)
Comparative targeting analysis of KLF1, BCL11A, and HBG1/2 in CD34+ HSPCs by CRISPR/Cas9 for the induction of fetal hemoglobin
Andres Lamsfus-Calle et al.
SCIENTIFIC REPORTS (2020)
CRISPR-Cas9 DNA Base-Editing and Prime-Editing
Ariel Kantor et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Base editing: advances and therapeutic opportunities
Elizabeth M. Porto et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Fetal Hemoglobin in Sickle Hemoglobinopathies: High HbF Genotypes and Phenotypes
Martin H. Steinberg
JOURNAL OF CLINICAL MEDICINE (2020)
Gene Editing of KLF1 to Cure Sickle Cell Disease
Kevin R. Gillinder et al.
BLOOD (2020)
BCL11A enhancer edited hematopoietic stem cells persist in rhesus monkeys without toxicity
Selami Demirci et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Editing aberrant splice sites efficiently restores β-globin expression in β-thalassemia
Shuqian Xu et al.
BLOOD (2019)
Gene Therapy for Beta-Hemoglobinopathies: Milestones, New Therapies and Challenges
Valentina Ghiaccio et al.
MOLECULAR DIAGNOSIS & THERAPY (2019)
Highly efficient therapeutic gene editing of human hematopoietic stem cells
Yuxuan Wu et al.
NATURE MEDICINE (2019)
CRISPR-Cas in Streptococcus pyogenes
Anais Le Rhun et al.
RNA BIOLOGY (2019)
CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations
Gregoire Cullot et al.
NATURE COMMUNICATIONS (2019)
TALEN-Mediated Gene Editing of HBG in Human Hematopoietic Stem Cells Leads to Therapeutic Fetal Hemoglobin Induction
Christopher T. Lux et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)
Correction of IVS I-110(G>A) β-thalassemia by CRISPR/Cas- and TALEN-mediated disruption of aberrant regulatory elements in human hematopoietic stem and progenitor cells
Petros Patsali et al.
HAEMATOLOGICA (2019)
Editing the Sickle Cell Disease Mutation in Human Hematopoietic Stem Cells: Comparison of Endonucleases and Homologous Donor Templates
Zulema Romero et al.
MOLECULAR THERAPY (2019)
Highly efficient editing of the β-globin gene in patient-derived hematopoietic stem and progenitor cells to treat sickle cell disease
So Hyun Park et al.
NUCLEIC ACIDS RESEARCH (2019)
Heme-regulated eIF2α kinase in erythropoiesis and hemoglobinopathies
Jane-Jane Chen et al.
BLOOD (2019)
Recent advances in the CRISPR genome editing tool set
Su Bin Moon et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2019)
Search-and-replace genome editing without double-strand breaks or donor DNA
Andrew V. Anzalone et al.
NATURE (2019)
A natural regulatory mutation in the proximal promoter elevates fetal globin expression by creating a de novo GATA1 site
Gabriella E. Martyn et al.
BLOOD (2019)
In vivo hematopoietic stem cell gene therapy ameliorates murine thalassemia intermedia
Hongjie Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Genome editing of HBG1 and HBG2 to induce fetal hemoglobin
Jean-Yves Metais et al.
BLOOD ADVANCES (2019)
Unbiased detection of CRISPR off-targets in vivo using DISCOVER-Seq
Beeke Wienert et al.
SCIENCE (2019)
Induction of fetal hemoglobin synthesis by CRISPR/Cas9-mediated editing of the human β-globin locus
Chiara Antoniani et al.
BLOOD (2018)
Reactivation of γ-globin in adult β-YAC mice after ex vivo and in vivo hematopoietic stem cell genome editing
Chang Li et al.
BLOOD (2018)
Direct Promoter Repression by BCL11A Controls the Fetal to Adult Hemoglobin Switch
Nan Liu et al.
CELL (2018)
Disruption of SOX6 gene using CRISPR/Cas9 technology for gamma-globin reactivation: An approach towards gene therapy of beta-thalassemia
Laleh Shariati et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Natural regulatory mutations elevate the fetal globin gene via disruption of BCL11A or ZBTB7A binding
Gabriella E. Martyn et al.
NATURE GENETICS (2018)
p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells
Robert J. Ihry et al.
NATURE MEDICINE (2018)
CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response
Emma Haapaniemi et al.
NATURE MEDICINE (2018)
Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia
A. A. Thompson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Hematopoietic stem cell transplantation for sickle cell disease: Progress and challenges
Monica L. Hulbert et al.
PEDIATRIC BLOOD & CANCER (2018)
Combining Zebrafish and CRISPR/Cas9: Toward a More Efficient Drug Discovery Pipeline
Carles Cornet et al.
FRONTIERS IN PHARMACOLOGY (2018)
A Nonhuman Primate Transplantation Model to Evaluate Hematopoietic Stem Cell Gene Editing Strategies for beta-Hemoglobinopathies
Olivier Humbert et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
Treatment of beta(654)-thalassaemia by TALENs in a mouse model
Yudan Fang et al.
CELL PROLIFERATION (2018)
Gene Therapy for Hemoglobinopathies
Marina Cavazzana et al.
HUMAN GENE THERAPY (2018)
Disruption of the BCL11A Erythroid Enhancer Reactivates Fetal Hemoglobin in Erythroid Cells of Patients with beta-Thalassemia Major
Nikoletta Psatha et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
Base editing: precision chemistry on the genome and transcriptome of living cells
Holly A. Rees et al.
NATURE REVIEWS GENETICS (2018)
Successful hematopoietic stem cell mobilization and apheresis collection using plerixafor alone in sickle cell patients
Erica B. Esrick et al.
BLOOD ADVANCES (2018)
Precision genome engineering through adenine and cytosine base editing
Jin-Soo Kim
NATURE PLANTS (2018)
Comparative analysis of three-dimensional chromosomal architecture identifies a novel fetal hemoglobin regulatory element
Peng Huang et al.
GENES & DEVELOPMENT (2017)
Programmable base editing of A.T to G.C in genomic DNA without DNA cleavage
Nicole M. Gaudelli et al.
NATURE (2017)
Gene Therapy in a Patient with Sickle Cell Disease
Jean-Antoine Ribeil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Preclinical modeling highlights the therapeutic potential of hematopoietic stem cell gene editing for correction of SCID-X1
Giulia Schiroli et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
One-Step Biallelic and Scarless Correction of a β-Thalassemia Mutation in Patient-Specific iPSCs without Drug Selection
Yali Liu et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2017)
A New Era for Hemoglobinopathies: More Than One Curative Option
Nikoletta Psatha et al.
CURRENT GENE THERAPY (2017)
In vivo transduction of primitive mobilized hematopoietic stem cells after intravenous injection of integrating adenovirus vectors
Maximilian Richter et al.
BLOOD (2016)
Sickle cell disease: Its molecular mechanism and the one drug that treats it
Frank A. Ferrone
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2016)
Regulation of hematopoietic development by ZBTB transcription factors
Takahiro Maeda
INTERNATIONAL JOURNAL OF HEMATOLOGY (2016)
Genetic disruption of the KLF1 gene to overexpress the -globin gene using the CRISPR/Cas9 system
Laleh Shariati et al.
JOURNAL OF GENE MEDICINE (2016)
Fetal haemoglobin in sickle-cell disease: from genetic epidemiology to new therapeutic strategies
Guillaume Lettre et al.
LANCET (2016)
CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells
Daniel P. Dever et al.
NATURE (2016)
A genome-editing strategy to treat β-hemoglobinopathies that recapitulates a mutation associated with a benign genetic condition
Elizabeth A. Traxler et al.
NATURE MEDICINE (2016)
Genome editing using CRISPR-Cas9 to create the HPFH genotype in HSPCs: An approach for treating sickle cell disease and β-thalassemia
Lin Ye et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Transcription factors LRF and BCL11A independently repress expression of fetal hemoglobin
Takeshi Masuda et al.
SCIENCE (2016)
Bcl11a Deficiency Leads to Hematopoietic Stem Cell Defects with an Aging-like Phenotype
Sidinh Luc et al.
CELL REPORTS (2016)
Correction of the sickle cell disease mutation in human hematopoietic stem/progenitor cells
Megan D. Hoban et al.
BLOOD (2015)
Plerixafor plus G-CSF-mobilized CD34+ cells represent an optimal graft source for thalassemia gene therapy
Garyfalia Karponi et al.
BLOOD (2015)
BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis
Matthew C. Canver et al.
NATURE (2015)
Functional footprinting of regulatory DNA
Jeff Vierstra et al.
NATURE METHODS (2015)
Editing the genome to introduce a beneficial naturally occurring mutation associated with increased fetal globin
Beeke Wienert et al.
NATURE COMMUNICATIONS (2015)
Both TALENs and CRISPR/Cas9 directly target the HBB IVS2-654 (C > T) mutation in β-thalassemia-derived iPSCs
Peng Xu et al.
SCIENTIFIC REPORTS (2015)
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
Shengdar Q. Tsai et al.
NATURE BIOTECHNOLOGY (2015)
CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling
Randall J. Platt et al.
CELL (2014)
Targeted genome editing in human repopulating haematopoietic stem cells
Pietro Genovese et al.
NATURE (2014)
In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system
Danilo Maddalo et al.
NATURE (2014)
Microhomology-based choice of Cas9 nuclease target sites
Sangsu Bae et al.
NATURE METHODS (2014)
IthaGenes: An Interactive Database for Haemoglobin Variations and Epidemiology
Petros Kountouris et al.
PLOS ONE (2014)
The new frontier of genome engineering with CRISPR-Cas9
Jennifer A. Doudna et al.
SCIENCE (2014)
Superior Long-Term Repopulating Capacity of G-CSF+Plerixafor-Mobilized Blood: Implications for Stem Cell Gene Therapy by Studies in the Hbbth-3 Mouse Model
Nikoleta Psatha et al.
HUMAN GENE THERAPY METHODS (2014)
COSMID: A Web-based Tool for Identifying and Validating CRISPR/Cas Off-target Sites
Thomas J. Cradick et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2014)
Hematopoietic Stem Cell Mobilization for Gene Therapy: Superior Mobilization by the Combination of Granulocyte-Colony Stimulating Factor Plus Plerixafor in Patients with β-Thalassemia Major
Evangelia Yannaki et al.
HUMAN GENE THERAPY (2013)
RNA-guided editing of bacterial genomes using CRISPR-Cas systems
Wenyan Jiang et al.
NATURE BIOTECHNOLOGY (2013)
Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A
Jian Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
An Erythroid Enhancer of BCL11A Subject to Genetic Variation Determines Fetal Hemoglobin Level
Daniel E. Bauer et al.
SCIENCE (2013)
TALE nucleases: tailored genome engineering made easy
Claudio Mussolino et al.
CURRENT OPINION IN BIOTECHNOLOGY (2012)
Bcl11a is essential for lymphoid development and negatively regulates p53
Yong Yu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria
Giedrius Gasiunas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Structural Basis for Sequence-Specific Recognition of DNA by TAL Effectors
Dong Deng et al.
SCIENCE (2012)
A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
Martin Jinek et al.
SCIENCE (2012)
Double-Strand Break End Resection and Repair Pathway Choice
Lorraine S. Symington et al.
ANNUAL REVIEW OF GENETICS, VOL 45 (2011)
Site-specific gene correction of a point mutation in human iPS cells derived from an adult patient with sickle cell disease
Jizhong Zou et al.
BLOOD (2011)
Genome Engineering With Zinc-Finger Nucleases
Dana Carroll
GENETICS (2011)
Genome-wide association study identifies genetic variants influencing F-cell levels in sickle-cell patients
Pallav Bhatnagar et al.
JOURNAL OF HUMAN GENETICS (2011)
TALEs of genome targeting
Jens Boch
NATURE BIOTECHNOLOGY (2011)
Correction of Sickle Cell Disease in Adult Mice by Interference with Fetal Hemoglobin Silencing
Jian Xu et al.
SCIENCE (2011)
In Situ Genetic Correction of the Sickle Cell Anemia Mutation in Human Induced Pluripotent Stem Cells Using Engineered Zinc Finger Nucleases
Vittorio Sebastiano et al.
STEM CELLS (2011)
Fetal hemoglobin in sickle cell anemia: genome-wide association studies suggest a regulatory region in the 5′ olfactory receptor gene cluster
Nadia Solovieff et al.
BLOOD (2010)
Transcriptional silencing of γ-globin by BCL11A involves long-range interactions and cooperation with SOX6
Jian Xu et al.
GENES & DEVELOPMENT (2010)
A global role for KLF1 in erythropoiesis revealed by ChIP-seq in primary erythroid cells
Michael R. Tallack et al.
GENOME RESEARCH (2010)
A genome-wide association identified the common genetic variants influence disease severity in β0-thalassemia/hemoglobin E
Manit Nuinoon et al.
HUMAN GENETICS (2010)
Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobin
Joseph Borg et al.
NATURE GENETICS (2010)
Genome editing with engineered zinc finger nucleases
Fyodor D. Urnov et al.
NATURE REVIEWS GENETICS (2010)
A novel human gamma-globin gene vector for genetic correction of sickle cell anemia in a humanized sickle mouse model: critical determinants for successful correction
Ajay Perumbeti et al.
BLOOD (2009)
LRF Is an Essential Downstream Target of GATA1 in Erythroid Development and Regulates BIM-Dependent Apoptosis
Takahiro Maeda et al.
DEVELOPMENTAL CELL (2009)
Correction of Murine Sickle Cell Disease Using γ-Globin Lentiviral Vectors to Mediate High-level Expression of Fetal Hemoglobin
Tamara I. Pestina et al.
MOLECULAR THERAPY (2009)
Developmental and species-divergent globin switching are driven by BCL11A
Vijay G. Sankaran et al.
NATURE (2009)
Chromosomal translocations induced at specified loci in human stem cells
Erika Brunet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Global epidemiology of haemoglobin disorders and derived service indicators
Bernadette Modell et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2008)
Long-range regulation of α globin gene expression during erythropoiesis
Douglas R. Higgs et al.
CURRENT OPINION IN HEMATOLOGY (2008)
Zinc-finger nucleases: The next generation emerges
Toni Cathomen et al.
MOLECULAR THERAPY (2008)
Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases
Elena E. Perez et al.
NATURE BIOTECHNOLOGY (2008)
Regulation of DNA repair throughout the cell cycle
Dana Branzei et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
In vivo selection of genetically modified erythroblastic progenitors leads to long-term correction of β-thalassemia
Annarita Miccio et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
DNA polymorphisms at the BCL11A, HBS1L-MYB, and β-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease
Guillaume Lettre et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A
Vijay G. Sankaran et al.
SCIENCE (2008)
A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15
Stephan Menzel et al.
NATURE GENETICS (2007)
CRISPR provides acquired resistance against viruses in prokaryotes
Rodolphe Barrangou et al.
SCIENCE (2007)
Generation of mice harboring a Sox6 conditional null allele
Bogdan Dumitriu et al.
GENESIS (2006)
A global role for EKLF in definitive and primitive erythropoiesis
D Hodge et al.
BLOOD (2006)
Sox6 directly silences epsilon globin expression in definitive erythropoiesis
Zanhua Yi et al.
PLOS GENETICS (2006)
Fusion genes and rearranged genes as a linear function of chromosome aberrations in cancer
F Mitelman et al.
NATURE GENETICS (2004)
Conservative homologous recombination preferentially repairs DNA double-strand breaks in the S phase of the cell cycle in human cells
N Saleh-Gohari et al.
NUCLEIC ACIDS RESEARCH (2004)
Extended β-globin locus control region elements promote consistent therapeutic expression of a γ-globin lentiviral vector in murine β-thalassemia
H Hanawa et al.
BLOOD (2004)
Bcl11a is essential for normal lymphoid development
PT Liu et al.
NATURE IMMUNOLOGY (2003)
A novel murine model of Cooley anemia and its rescue by lentiviral-mediated human β-globin gene transfer
S Rivella et al.
BLOOD (2003)
Correction of sickle cell disease in transgenic mouse models by gene therapy
R Pawliuk et al.
SCIENCE (2001)
The BCL11 gene family:: involvement of BCL11A in lymphoid malignancies
E Satterwhite et al.
BLOOD (2001)
Therapeutic haemoglobin synthesis in β-thalassaemic mice expressing lentivirus-encoded human β-globin
C May et al.
NATURE (2000)
分享论文
